期刊文献+

Progression of solitary and multifocal papillary thyroid carcinoma- a retrospective study of 368 patients 被引量:9

Progression of solitary and multifocal papillary thyroid carcinoma- a retrospective study of 368 patients
原文传递
导出
摘要 Background Papillary thyroid carcinoma (PTC) represents one of the most frequent endocrine malignancies. Several factors have been found to be involved in determining the outcome of treatment for patients with PTC. Large tumor size, diagnosis at an early age, extra-thyroidal invasion, aggressive histological variants, and distant metastases are the most important determinants of a poor outcome. BRAF^V600E mutation has been found to be a major genetic alteration in PTC. This study aimed to evaluate progression in patients with multifocal and solitary PTC. Methods We performed a retrospective study to analyze 368 patients with PTC who underwent surgery, including 282 patients with solitary PTC and 86 patients with multifocal PTC. The status ofBRAF^V600E mutation in all tumor foci from multifocal PTC was detected. Results Our study suggested that multifocal PTC was more related to lymph node metastasis and vascular invasion than solitary PTC. However, the distant metastasis rate and 10-year survival rate showed no difference between these two groups. The number of tumor loci did not affect progression of disease in multifocal PTC patients. Lymph node metastasis in multifocal PTC patients was associated with larger tumors, diagnosis at early stage, and extra-thyroidal invasion. Conclusion The status of BRAF^V600Emutation was more frequent in multifocal PTC patients with lymph node metastasis and diagnosis at later age. Background Papillary thyroid carcinoma (PTC) represents one of the most frequent endocrine malignancies. Several factors have been found to be involved in determining the outcome of treatment for patients with PTC. Large tumor size, diagnosis at an early age, extra-thyroidal invasion, aggressive histological variants, and distant metastases are the most important determinants of a poor outcome. BRAF^V600E mutation has been found to be a major genetic alteration in PTC. This study aimed to evaluate progression in patients with multifocal and solitary PTC. Methods We performed a retrospective study to analyze 368 patients with PTC who underwent surgery, including 282 patients with solitary PTC and 86 patients with multifocal PTC. The status ofBRAF^V600E mutation in all tumor foci from multifocal PTC was detected. Results Our study suggested that multifocal PTC was more related to lymph node metastasis and vascular invasion than solitary PTC. However, the distant metastasis rate and 10-year survival rate showed no difference between these two groups. The number of tumor loci did not affect progression of disease in multifocal PTC patients. Lymph node metastasis in multifocal PTC patients was associated with larger tumors, diagnosis at early stage, and extra-thyroidal invasion. Conclusion The status of BRAF^V600Emutation was more frequent in multifocal PTC patients with lymph node metastasis and diagnosis at later age.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第24期4434-4439,共6页 中华医学杂志(英文版)
关键词 papillary thyroid carcinoma multifocal solitary BRAF^V600E mutation papillary thyroid carcinoma multifocal, solitary BRAF^V600E mutation
  • 相关文献

参考文献2

二级参考文献37

  • 1Hazard JB, Hawk WA, Crile GJ. Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity. J Clin Endocrinol Metab 1959; 19:152-161.
  • 2Schroder S, Holl K, Padberg BC. Pathology of sporadic and hereditary medullary thyroid carcinoma. In: Raue F, eds. Medullary thyroid carcinoma. New York: Springer-Verlag; 1992: 19-45.
  • 3Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary throid cancer. Oncotogist 2008; 13: 539-547.
  • 4You YN, Lakhani V, Wells SA Jr, Moley JF. Medullary thyroid cancer. Surg Oncol Clin N Am 2006; 15: 639-660.
  • 5Hegedus L, Karstrup S. Ultrasonography in the evaluation of cold thyroid nodules. Eur J Endocrinol 1998; 138:30-31.
  • 6Sailer B, Moeller L, Gorges R, Janssen OE, Mann K. Role of conventional ultrasound and color Doppler sonography in the diagnosis of medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes 2002; 110: 403-407.
  • 7Gorman B, Charboneau JW, James EM, Reading CC, Wold LE, Grant CS, et al. Medullary thyroid carcinoma: role of high-resolution US. Radiology 1987; 62: 147-150.
  • 8Kim SH, Kim BS, Jung SL, Lee JW, Yang PS, Kang B J, et al. Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Korean J Radiol 2009; 10: 101-105.
  • 9Jun P, Chow LC, Jeffrey RB. The sonographic features of papillary thyroid carcinomas: pictorial essay. Ultrasound Q 2005; 21: 39-45.
  • 10Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy. J Ultrasound Med 2004; 23: 1455-1464.

共引文献10

同被引文献23

引证文献9

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部